Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can pause Mounjaro for a holiday, but it is worth thinking through what happens when you do. Stopping a weekly injection even briefly affects appetite, weight trajectory and how your body responds when you restart. This page lays out the real factors so you can make a clear decision with your prescriber. Mounjaro (tirzepatide) is a prescription-only medicine, and any planned break should be discussed with your clinical team before you travel.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There is a common assumption that skipping a few injections on holiday is low-stakes, like pausing a vitamin. In practice, tirzepatide works by continuously signalling two gut-hormone receptors that slow gastric emptying and reduce appetite. When doses are missed, those signals fade. Most people notice hunger returning before they notice any weight change, sometimes within the first week.
That said, a short pause is not a clinical catastrophe. The question is whether the disruption is worth it for your particular situation, and the answer depends on how long you have been on treatment, which dose you are taking, where you are in your titration, and how your body has responded so far. Someone six months into treatment at 10 mg is in a very different position from someone on their second pen at 5 mg. These are exactly the factors a prescriber considers, which is why this conversation belongs in a clinical review rather than a forum thread.
There is also a practical consideration worth raising before anything else: for many people, the simplest plan is to take Mounjaro with them. The pen is discreet, the injection technique is straightforward once established, and with a travel cool bag the cold chain is manageable across most holiday destinations. If you are weighing up the logistics, it may be less complicated than you think. For a broader look at how Mounjaro works and what treatment involves, that page covers the full picture.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed participants for 72 weeks and showed average weight reductions of around 20–21% at the highest dose. Crucially, extension and follow-up analyses from the wider tirzepatide programme consistently show that a meaningful proportion of lost weight returns after stopping, and that appetite rebounds alongside it. This is not a sign that treatment failed; it reflects how the medicine works. The biology driving excess weight does not resolve when treatment pauses, it simply becomes less actively managed.
A two-week holiday break will not undo months of progress in one go, but it sets the trajectory briefly in reverse. The longer the gap, the more pronounced that reversal tends to be. If you are curious about how long Mounjaro takes to produce noticeable results, that context is useful here too: the same gradual mechanism that builds results gradually also unwinds them, which is reassuring in one sense.
NHS guidance on weight-management medicines notes that ongoing use is generally needed to maintain results, and the NHS tirzepatide patient information page is worth reading before travel for practical storage and missed-dose guidance. For the exact room-temperature window your pen can tolerate, the Patient Information Leaflet in the box is the authoritative source.
If your pause runs longer than four weeks, your prescriber will need to consider whether you restart at your previous dose or step back down the titration schedule. This is not a bureaucratic hurdle. Starting again at a higher dose after a gap carries a greater risk of the gastrointestinal side effects (nausea, loose stools, stomach discomfort) that the gradual titration is designed to minimise. A prescriber who has reviewed your history will advise you on the safest re-entry point.
If you are on a shorter break, two weeks say, and your prescriber is satisfied with your progress, you may be able to resume at your current dose. Do not adjust this yourself. Guidance on stopping or pausing Mounjaro covers the wider question of how to do this safely, and when stopping might be clinically appropriate is a related question worth reading if your holiday plans have prompted broader thinking about your treatment timeline.
One thing worth factoring in: the timing of your last injection before you leave. If your regular injection day falls mid-holiday, discuss with your prescriber whether to bring a pen or shift the schedule by a day or two beforehand. Small timing adjustments like this are common and manageable with prescriber input. You can also read more about stopping Mounjaro specifically in the context of weight loss goals if your thinking has moved beyond the holiday itself.
Whatever you decide, there are a few things to sort before you travel. First, have the conversation with your prescriber rather than after. Second, check your pen's storage requirements in the Patient Information Leaflet and plan your cool storage accordingly. Third, confirm the status of your next clinical review: if a repeat order is due while you are away, factor that into your timing. At nume, every repeat order goes through a fresh clinical review, so planning ahead avoids a gap on your return.
If cost is part of your thinking around whether to pause treatment, it is worth looking at what Mounjaro costs privately in the UK to understand what makes up a legitimate treatment price. Treatment decisions and financial decisions are separate, but it helps to have the full picture. If after reading this you would like to talk through your holiday plans with a prescriber, check your eligibility with our clinical team. A real prescriber reads every consultation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.